[Federal Register Volume 65, Number 135 (Thursday, July 13, 2000)]
[Notices]
[Page 43378]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-17690]



[[Page 43378]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director; Notice of Meeting

    Pursuant to Pub. L. 92-463, notice is hereby given of a meeting of 
the Advisory Committee to the Director, NIH.

    The entire meeting will be open to the public as indicated 
below, with attendance limited to space available. Individuals who 
plan to attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should inform the 
Contact Person listed below in advance of the meeting. The meeting 
will take place via conference call with the members. A speaker 
phone will be installed in the conference room for the public to 
listen to the discussion.
    Name of Committee: Advisory Committee to the Director, NIH.
    Date: July 14, 2000.
    Time: 12-1 p.m.
    Agenda: To discuss and provide advice on the first part of the 
Report from the Working Group on NIH Oversight of Clinical Gene 
Transfer Research.
    Place: National Institutes of Health, 1 Center Drive, Building 
1, Room 151, Bethesda, Maryland 20892.
    Contact Person: Ms. Janice C. Ramsden, Special Assistant to the 
Acting Director, NIH, National Institutes of Health, Building 1, 
Room 235, Bethesda, Maryland 20892, [email protected], Telephone: (301) 
496-0959.
    This notice is being published less than fifteen days in advance 
of the meeting due to scheduling conflicts among the members.

    Dated: July 6, 2000.
LaVerne Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-17690 Filed 7-12-00; 8:45 am]
BILLING CODE 4140-01-M